$201.0 Million
Cytokinetics, Incorporated
Follow-On Offering
Active Bookrunner
$142.6 Million
TCR2 Therapeutics
Follow-On Offering
Active Bookrunner
$48.0 Million
TELA Bio, Inc.
Follow-On Offering
Active Bookrunner
$120.8 Million
Oyster Point Pharma, Inc.
Follow-On Offering
Active Bookrunner
$125.0 Million
Avadel Pharmaceuticals
Follow-On Offering
Active Bookrunner
$42.7 Million
Xeris Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
$201.3 Million
Deciphera Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
$266.8 Million
Arrowhead Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
$315.2 Million
CRISPR Therapeutics AG
Follow-On Offering
Active Bookrunner
$172.3 Million
NextCure, Inc.
Follow-On Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2024 Piper Sandler Companies. Since 1895. All rights reserved.